Regenxbio
RGNX
RGNX
187 hedge funds and large institutions have $1.24B invested in Regenxbio in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 50 increasing their positions, 62 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3.22% less ownership
Funds ownership: 76.29% → 73.08% (-3.2%)
19% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 62
Holders
187
Holding in Top 10
3
Calls
$15.7M
Puts
$5.24M
Top Buyers
| 1 | +$21.5M | |
| 2 | +$9.08M | |
| 3 | +$7.39M | |
| 4 |
Goldman Sachs
New York
|
+$6.86M |
| 5 |
FM
Frazier Management
Seattle,
Washington
|
+$5.86M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$11.3M | |
| 3 | -$7.94M | |
| 4 |
BlackRock
New York
|
-$7.8M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$7.79M |